HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Zaffaroni Selected Research

BBR 3464 (BBR3464)

5/2001Activity of a trinuclear platinum complex in human ovarian cancer cell lines sensitive and resistant to cisplatin: cytotoxicity and induction and gene-specific repair of DNA lesions.
3/2001Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Zaffaroni Research Topics

Disease

20Neoplasms (Cancer)
06/2014 - 02/2000
6Melanoma (Melanoma, Malignant)
09/2002 - 02/2000
5Ovarian Neoplasms (Ovarian Cancer)
08/2002 - 05/2000
4Carcinoma (Carcinomatosis)
07/2004 - 05/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014 - 09/2002
3Liposarcoma
10/2009 - 03/2008
2Sarcoma (Soft Tissue Sarcoma)
01/2021 - 05/2013
2Disease Progression
01/2017 - 06/2014
2Carcinogenesis
01/2013 - 01/2005
2Breast Neoplasms (Breast Cancer)
03/2009 - 01/2001
2Prostatic Neoplasms (Prostate Cancer)
12/2007 - 07/2004
2Osteosarcoma (Osteogenic Sarcoma)
09/2002 - 10/2001
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2017
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2014
1Solitary Fibrous Tumors
09/2013
1Hypoglycemia (Reactive Hypoglycemia)
09/2013
1Paraganglioma (Paragangliomas)
06/2013
1Pheochromocytoma
06/2013
1Ewing Sarcoma (Sarcoma, Ewing)
05/2013
1Poisoning
01/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012
1Neutropenia
01/2012
1Endometrial Neoplasms (Endometrial Cancer)
01/2012
1Alveolar Soft Part Sarcoma
07/2011
1Mesothelioma
07/2003
1Papillary Thyroid Cancer
07/2003

Drug/Important Bio-Agent (IBA)

14Telomerase (Telomerase Reverse Transcriptase)IBA
10/2009 - 02/2000
7EnzymesIBA
05/2013 - 06/2001
5Cisplatin (Platino)FDA LinkGeneric
03/2014 - 03/2001
4pazopanibFDA Link
01/2017 - 09/2013
4PlatinumIBA
03/2014 - 03/2001
4Pharmaceutical PreparationsIBA
03/2014 - 09/2002
4Catalytic RNA (Ribozymes)IBA
02/2003 - 02/2000
3Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 05/2000
3Sunitinib (Sutent)FDA Link
11/2014 - 07/2011
3Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2013 - 01/2012
3Proteins (Proteins, Gene)FDA Link
03/2009 - 06/2001
3Cell ExtractsIBA
09/2002 - 02/2000
2Bevacizumab (Avastin)FDA Link
11/2014 - 09/2013
2Angiogenesis InhibitorsIBA
06/2014 - 05/2013
2telomerase RNA (bTR)IBA
04/2008 - 06/2001
2Messenger RNA (mRNA)IBA
12/2007 - 06/2001
2Cell-Penetrating PeptidesIBA
12/2007 - 05/2000
2Nucleic AcidsIBA
12/2007 - 05/2000
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2001 - 02/2000
2BBR 3464 (BBR3464)IBA
05/2001 - 03/2001
2hammerhead ribozymeIBA
10/2000 - 02/2000
2RNA (Ribonucleic Acid)IBA
10/2000 - 02/2000
1Sorafenib (BAY 43-9006)FDA Link
11/2014
1regorafenibIBA
11/2014
1Axitinib (AG 013736)IBA
11/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2014
1ascrinvacumabIBA
06/2014
1Monoclonal AntibodiesIBA
06/2014
1LigandsIBA
03/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2014
1Adenosine Triphosphate (ATP)IBA
03/2014
1Drug CombinationsIBA
03/2014
1Interleukin-8 (Interleukin 8)IBA
01/2014
1CytokinesIBA
01/2014
1TriazinesIBA
09/2013
1Temozolomide (Temodar)FDA LinkGeneric
09/2013
1Dacarbazine (DIC)FDA LinkGeneric
09/2013
1Heparin (Liquaemin)FDA LinkGeneric
05/2013
1heparanaseIBA
05/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013
1SST 0001IBA
05/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2013
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2013
1AnticoagulantsIBA
05/2013
1Conditioned Culture MediaIBA
05/2013
1Tyrosine (L-Tyrosine)FDA Link
05/2013
1A-Form DNA (A-DNA)IBA
01/2013
1CamptothecinIBA
01/2013
1MicroRNAs (MicroRNA)IBA
01/2013
1Topotecan (Hycamtin)FDA LinkGeneric
01/2012
1Irinotecan (Camptosar)FDA LinkGeneric
01/2012
1LactonesIBA
01/2012
1PoisonsIBA
01/2012
1namitecanIBA
01/2012
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
01/2012
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
07/2011
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2011
1Biological ProductsIBA
01/2011
1Small Interfering RNA (siRNA)IBA
03/2009
1Caspase 3 (Caspase-3)IBA
03/2009
1ChromatinIBA
04/2008
1ParaffinIBA
03/2008
1Formaldehyde (Formol)FDA Link
03/2008
1Peptides (Polypeptides)IBA
12/2007
1OligonucleotidesIBA
01/2005
1Phosphorothioate OligonucleotidesIBA
07/2004
1RNA Precursors (Precursor, mRNA)IBA
07/2004
1OxindolesIBA
07/2003
1Oncogene Proteins (Oncogene Protein)IBA
07/2003

Therapy/Procedure

6Therapeutics
03/2014 - 02/2000
3Drug Therapy (Chemotherapy)
01/2017 - 06/2001
1Aftercare (After-Treatment)
09/2013
1Radiotherapy
06/2013
1Hyperthermic Intraperitoneal Chemotherapy
07/2003